Analysts Offer Insights on Healthcare Companies: Alexion Pharmaceuticals (NASDAQ: ALXN), Quest Diagnostics Inc (NYSE: DGX) and Icon plc (NASDAQ: ICLR)

By Ryan Adsit

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alexion Pharmaceuticals (NASDAQ: ALXN), Quest Diagnostics Inc (NYSE: DGX) and Icon plc (NASDAQ: ICLR).

Alexion Pharmaceuticals (NASDAQ: ALXN)

In a report released yesterday, Alethia Young from Credit Suisse maintained a Buy rating on Alexion Pharmaceuticals (NASDAQ: ALXN), with a price target of $160. The company’s shares closed yesterday at $130.39.

According to TipRanks.com, Young is a 2-star analyst with an average return of 0.6% and a 46.7% success rate. Young covers the Healthcare sector, focusing on stocks such as Achillion Pharmaceuticals, Ionis Pharmaceuticals Inc, and Vertex Pharmaceuticals.

Currently, the analyst consensus on Alexion Pharmaceuticals is Strong Buy and the average price target is $162, representing a 24.2% upside.

In a report issued on February 7, J.P. Morgan also reiterated a Buy rating on the stock with a $170 price target.
Quest Diagnostics Inc (NYSE: DGX)

Credit Suisse analyst Robert Willoughby maintained a Hold rating on Quest Diagnostics Inc (NYSE: DGX) on February 15 and set a price target of $81. The company’s shares closed yesterday at $95.30, close to its 52-week high of $96.45.

According to TipRanks.com, Willoughby is a 4-star analyst with an average return of 8.0% and a 66.3% success rate. Willoughby covers the Services sector, focusing on stocks such as Service Corp International, Walgreens Boots Alliance, and The Advisory Board.

Quest Diagnostics Inc has an analyst consensus of Moderate Buy, with a price target consensus of $96.80.

Icon plc (NASDAQ: ICLR)

Credit Suisse analyst Erin Wilson maintained a Buy rating on Icon plc (NASDAQ: ICLR) yesterday and set a price target of $90. The company’s shares closed yesterday at $87.78, close to its 52-week high of $88.05.

According to TipRanks.com, Wilson is a 4-star analyst with an average return of 8.2% and a 64.6% success rate. Wilson covers the Healthcare sector, focusing on stocks such as Dentsply International Inc, Quest Diagnostics Inc, and Phibro Animal Health.

Icon plc has an analyst consensus of Moderate Buy, with a price target consensus of $80.40.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.